Group ACYW135 Meningococcal Polysaccharide Vaccine (Zhejiang Vacin Bio-Pharmaceutical)

ACYW135群脑膜炎球菌多糖疫苗（艾美卫信生物药业）

Report date: 2024/04/24 11:04:05

Base Information

Drug NameGroup ACYW135 Meningococcal Polysaccharide Vaccine (Zhejiang Vacin Bio-Pharmaceutical)

Drug Alias NameTetravalent meningococcal polysaccharide vaccine (Zhejiang Vacin Bio-Pharmaceutical)ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (Zhejiang Vacin Bio-Pharmaceutical)

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[5]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningitisMeningitis, Meningococcal

Global Approved IndicationsMeningitis

Approved Indications in ChinaMeningitis

Original Approved Country/TerritoryMainland China

Original Approved Date2018/10/15

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd

Inactive CompaniesN/A

Active IndicationsMeningitis

Inactive IndicationsMeningitis, Meningococcal

Other Information

ATC CodeJ07AH04